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Abstract
Introduction: The STOP TB Partnership aims to improve global tuberculosis (TB) control through expanding access
to the directly observed treatment short course (DOTS) strategy. One approach to this is ‘Engaging all Care
Providers’, which evolved from ‘Public-Private Mix (PPM) DOTS’. The overall aim of this study was to systematically
assess whether and to what degree the STOP TB Partnership’s four global objectives of engaging all care providers
are met through existing PPM interventions. These four objectives are; 1) Increase TB case detection; 2) Improve TB
treatment outcomes; 3) Enhance access and equity; 4) Reduce financial burden on patients. The specific objectives
of this assessment were to 1) Understand what PPM means to the STOP TB Partnership’s PPM Subgroup and to
National Tuberculosis Programme managers; 2) Scope the nature of existing country-level PPM interventions and 3)
Review PPM practice against the global PPM objectives.
Methods: We undertook a systematic, multi-facetted assessment. The methods included interviews with National
Tuberculosis Programme managers from high burden countries, clarification of key issues with the STOP TB
Partnership PPM secretariat and a review of publicly accessible reports and published articles on PPM projects. Both
the literature review and interviews with the National Tuberculosis Programme managers yielded data on project
characteristics; PPM models at country level; National Tuberculosis Programme partners; and mechanisms for
engagement. Matrices were developed from the literature review and the interviews to show the relationship
between services and service providers for different PPM projects. Data from the literature were assessed against
each of the four global PPM objectives.
Results: Twelve National Tuberculosis Programme managers from high burden countries were interviewed about
the scope of PPM partnerships. Understanding of PPM and types of engaged providers varied considerably;
‘private-for-profit qualified clinical providers’ were the dominant category. The literature review yielded information
on 22 projects in which ‘private-for-profit qualified clinical providers’ were again the dominant category. The
contributions made by ‘private-for-profit qualified clinical providers’ and ‘Non Governmental Organisation qualified
clinical providers’, were assessed against the four global PPM objectives. Reporting on tuberculosis case detection
and treatment outcomes was generally good and demonstrated important PPM contributions in these areas.
Reporting on equity, access and reduced patient costs was often lacking or inconclusive.
Conclusions: PPM has improved case detection and treatment outcomes among patients seeking care with
private providers. Evidence on reducing patient costs is inconclusive, and there is scope for increasing equity in
access to care by systematically engaging those providers who are the primary agents for poor people seeking
health care. Guidelines outlining which types of providers best contribute to achieving the four global objectives,
along with the resources required by National Tuberculosis Programs for such engagement is needed.
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Tuberculosis (TB) causes 1.8 million deaths annually.
The majority of cases are found in low or low-middle
income countries[1] and studies in both high-income[2]
and low-income[3] countries demonstrate significantly
higher rates of TB in their poorer populations.
Directly observed treatment short course (DOTS) was
introduced as the Global Strategy to address TB in 1994
[4]. DOTS comprises five key components: 1) Political
commitment; 2) Case detection through quality-assured
bacteriology; 3) Standardized treatment with supervision
and patient support; 4) An effective drug supply and
management system; 5) Monitoring and evaluation sys-
tem and impact measurement [5]. It is still seen as the
corner stone of TB control today. Its success is largely
measured through case detection and treatment success
rates. Case detection requires that TB is primarily diag-
nosed in a patient through bacteriology and is reported
within the national surveillance system and hence to
WHO[6]. Treatment success is achieved when a patient
who was sputum smear positive completes treatment
and is cured (they become smear negative) or when a
patient who was smear negative completes treatment
[7]. Originally DOTS was primarily implemented
through National Tuberculosis Programmes (NTPs). It
was recognised, however, that health systems are plura-
listic and that private practitioners (often general practi-
tioners) functioning in isolation from NTPs were an
important source of care for many patients but that
their services did not meet international standards[8].
The potential for engaging private providers for TB con-
trol was described in Uplekar et al, 2001[9]. By 2003 a
strategy, known as Public-Private Mix DOTS (PPM
DOTS), for engaging private providers in order to
improve TB control had been established[10] and by
2006 was supported by the International Standards for
TB Care[11]. During the subsequent few years the PPM
DOTS concept expanded to encompass engagement
with a range of providers, including some semi-qualified
providers[12], traditional providers[13] and public and
private hospitals[14,15]. PPM DOTS is now known as
‘PPM for TB Care and Control’ and is a core compo-
nent of the WHO STOP TB Strategy, entitled ‘Engage
All Care Providers’[16] and supported by a toolkit to
assist implementation[17].
PPM for TB Care and Control (PPM) is by definition
a complex, context-specific, health system intervention
[18] and it is seen as a catalyst[19,20] for meeting the
WHO and Stop TB Partnership targets for global TB
control[16,21-23]. Guidelines in 2006 for implementing
PPM[24] stressed the need for NTPs to set their own
objectives but to link these to the Millennium Develop-
ment Goals (MDGs). They also illustrated the
mechanisms through which PPM can facilitate attain-
ment of the MDGs (shown in Figure 1). The most
recent PPM toolkit has now developed this thinking
further and articulates specific PPM objectives[17]:
1) Increase TB case detection
2) Improve TB treatment outcome
3) Enhance access and equity
4) Reduce financial burden on patients
There have been strong calls for evaluations of health
system interventions like PPM in order to promote
further policy and practice development[25,26]. Several
evaluations and cross project comparisons of PPM pro-
jects have been published [27-31], primarily focusing on
case notifications and treatment outcomes. Some studies
assessing the cost effectiveness of individual PPM pro-
jects have also been published[32-35]. While these have
been helpful in assessing whether PPM can increase
case notifications and improve treatment success, they
have not attempted to take a comprehensive, systematic
approach to synthesising all the evidence, they have not
addressed the other PPM objectives, nor assessed which
types of provider are effective at addressing which of the
objectives. Our aim was to understand the range of
PPM interventions (including but not limited to those
reported through peer reviewed publications) and sys-
tematically to assess whether, and to what degree, these
global objectives are mett h r o u g he x i s t i n gP P M
interventions.
The phrase ‘systematic assessment’ was chosen
because we have tried to mirror the concept used in sys-
tematic reviews [36-38], the specific approach used in
this review is adapted from a systematic review by Bosh-
Capblanch and Garner [39].
Methods
The review comprised three objectives:
￿ Understanding what PPM for TB care and control
means to the STOP TB Partnership’s PPM Subgroup
and to NTP managers
￿ Mapping the scope of country-level PPM
interventions
￿ Reviewing practice against global PPM objectives
Understanding what PPM for TB care and control means
to the STOP TB Partnership’s PPM Subgroup and to NTP
managers
The websites and publications of WHO and the STOP
TB Partnership were searched for definitions of PPM in
May 2009. Further clarifications concerning PPM’ss p e -
cific objectives were sought by email from the STOP TB
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websites and publications were checked again in
November 2010.
We conducted interviews with 12 of the 22 NTP
managers from high burden countries during the
DOTS Expansion Working Group (http://www.stoptb.
org/wg/dots_expansion) meeting in October 2009, to
learn about the scope of PPM at country level, the
kind of providers engaged and what activities are
undertaken by each partner. Convenience sampling
was used for the selection of NTP managers, while
ensuring representation from each continent (see Fig-
ure 2). Summaries of key discussion points and ‘PPM
diagrams’ showing the relationships between different
PPM partners were drawn up (based on a previously
published template[40]) and sent back to the respective
NTP manager for comments. Five responded with
comments and/or corrections. After amendment, the
diagrams were sent back for final approval, which was
received from all.
Mapping country-level PPM interventions
This comprised the following steps, each of which is dis-
cussed in detail below:
a) Developing selection criteria for the literature
review
b) Sourcing, reviewing and collating documents and
the results of the NTP managers’ interviews
c) Developing two matrices outlining actors and ser-
vices - one from the literature reviews, one from the
interviews
a) Selection, inclusion and exclusion criteria for literature
review
The global objectives of PPM were not articulated
before the PPM subgroup of the DOTS Expansion
Source: Engaging All Health Care Providers in TB Control: Guidance on Implementing 
Public-Private Mix Approaches[24]  
Improve TB
management 
xImprove quality of 
diagnosis
xImprove case 
management
xImprove referral 
routines
xImprove recording/ 
reporting
Process
Adapt services to the 
poor
xInvolve providers that 
serve the poor
xProvide drugs free of 
charge
xReduce unnecessary 
tests
xDecentralize DOT
TB control outcome
xIncrease case detection
xImprove success rate
xReduce drug resistance
TB control impact
xReduce TB incidence
xReduce TB prevalence
xReduce TB deaths 
Public health impact
Equity and poverty 
outcome
xImprove access for the 
poor
xDecrease diagnostic 
delay
xReduce patients’ direct 
and indirect costs
Poverty impact
xReduce poverty and 
hunger among people 
with TB and their 
families
M
D
G
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D
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Figure 1 Logical framework for linkages between PPM objectives, Tuberculosis (TB) control and Millennium Development Goals
(MDGs). Source: Engaging All Health Care Providers in TB Control: Guidance on Implementing Public-Private Mix Approaches[24].
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established in 2000[41]. The literature search was
therefore limited to material published after January
2000 and up to 7
th November 2010, using the
following search phrases; words where not searched
individually:
’Public Private Mix’; ‘PPM TB’; ‘PPM Tuberculosis’;
‘Public Private Mix TB’; ‘Public Private Mix
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a  NTP = National Tuberculosis Program  
b  E. Africa = East Africa 
c  W. Africa = West Africa 
d  S. America = South America  
e  S. Asia = South Asia 
f  S.E. Asia = South East Asia
NTP
a managers interviewed
Projects included from literature
NTP
a Managers and projects
NTP Managers Interviewed Projects included from literature
Continent Region Country Continent Region
Proj. 
ID Country Site Reference
Africa E.Africa
b  Kenya Africa North Africa A. Egypt  National 27,28,54
Mozambique East Africa B. Kenya Nairobi 28,29,30,65
Tanzania Southern Africa C. South Africa Western Cape 62
W.Africa
c  Burkina Faso West Africa  D. Nigeria Kaduna state  58
Nigeria Asia South Asia E. Bangladesh Damien Foundation 30,75
Americas S.America
d  Brazil F. India Bangalore 32,33
Asia S.Asia
e  Bangladesh G. Chennai 27,28,68
Pakistan H. Hyderabad   27,28,30,31,34,59,67 
S.E.Asia
f Cambodia I. Kerala 30,31,35,44,69
Indonesia J. Meerut 31,76
Myanmar K. Mumbai 30,31,60,61,77,78
Thailand L. New Delhi   27-31,34,48,79,80 
M. Pune 29,30,49,55
N. Nepal Lalitpur municipality  30,52,63,66 
O. Pakistan Thatta, district 56
Southeast Asia P. Indonesia Central Java 14,15
Q. Timika 53
R. Yogyakarta 14,15,30,81 
S. Myanmar Mandalay Division 50
T. SQH Franchise  30,51 
U. Philippines Manila 27,28,30,64,82,83
V. Vietnam Ho Chi Minh City 29,57,70,71
Figure 2 Countries represented in the study through NTP manager interviews and published literature [75-83].
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Page 4 of 19Tuberculosis’; ‘Private health care provision TB’; ‘Private
health care provision Tuberculosis’; ‘access TB’; ‘access
Tuberculosis’.
English language abstracts from all articles were initi-
ally included as were relevant publicly accessible reports,
not found in the peer-reviewed press.
The following exclusion criteria were applied to the
abstracts:
￿ Papers which did not focus on PPM models of TB
care provision
￿ Documents which were not available in their full
text form from the UK universities library network
Reference lists of full text articles were screened for
relevant references, with the same selection and exclu-
sion criteria applied. Five of the resulting full text arti-
cles reviewed were excluded because they did not focus
on implemented PPM projects. Figure 3 shows that the
search criteria led to an initial discovery of 2,588
abstracts, while the exclusion criteria narrowed these
down to 45 relevant articles and reports.
b) Sourcing, reviewing and collating documents
The 45 documents were reviewed and grouped by pro-
ject. If more than one of the documents discussed dif-
ferent aspects of the same PPM project they were
grouped as one. Twenty-two projects were identified
and are listed in Figure 2. They are named by the coun-
try and/or site in which they were performed. They will
hereafter be known as the ‘projects’.
c) Development of matrices
The PPM diagrams from the interviews served as a tem-
plate for mapping providers and services identified
through the literature. The Thai PPM model, shown in
Figure 4, is an example.
Terminology regarding partners, the services they
delivered and the inputs they received differed across
the publications and between NTP managers (known
collectively henceforth as our sources), we therefore
grouped these into common themes, which we termed
‘aggregated’ partners, services or inputs. For partners of
TB programmes these were: other public sector heath
partners (PSHP), other public sector partners (OPS), pri-
vate-for-profit partners (PFP) and non-governmental
organisations (NGOs). For clarity, a ‘qualified doctor’
was defined as someone qualified in bio-medicine. Prac-
titioners with other types of qualifications are, for the
purpose of this review, categorised as unqualified
practitioners.
Services delivered were aggregated into 15 categories
ranging from advocacy to patient follow up. Finally,
NTP inputs were collapsed into 12 categories ranging
from provision of advocacy, communication and social
mobilisation (ACSM) to actual building of a TB clinic.
 
 
     
 
 
 
 
 
 
 
 
 
English language 
(February 2000-
November 2010) 
abstracts screened n = 
2588
Abstracts excluded n = 2516
Abstracts retrieved for 
more detail n= 72 Abstracts excluded due to lack of 
available full text documents n = 16
Full text articles 
retrieved  
n = 56
Documents excluded n = 11
Not TB public- private  
collaboration = 1
Articles of pre-PPM project 
intervention = 5
Not project specific articles = 5 Articles and reports 
included in the 
analysis n = 45
(43 articles, 2 reports)
Figure 3 Process used for literature screening and selection.
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Page 5 of 19For details on how specific partners, services, or inputs
were grouped, see additional files 1, 23.
A matrix was constructed representing partners in
columns with services and inputs in rows.
d) Using the matrix to assess PPM projects
This matrix was completed once from the NTP manager
interviews (Table 1) and a second time from the litera-
ture (Table 2). A mark was put in the matrix each time
a source identified that a partner was engaged in deli-
vering a specific service or the NTP provided a specific
input. For each type of partner the total number of
marks across all services and inputs was calculated to
yield a partner ‘score’.
The ‘score’ w a su s e da sap r o x ym e a s u r eo fe n g a g e -
ment. Thus the highest ‘score’ among the types of pro-
viders indicated which provider type is most
commonly engaged, the highest ‘score’ of services indi-
cated which service type was the most commonly
given by the providers, and the highest ‘score’ of inputs
indicated which input type was the most commonly
received by the providers. The matrices thus provided
an overview of the frequency with which an aggregated
partner group provided an aggregated service type, and
received different aggregated inputs. The groups which
appeared with the greatest frequency were then
selected for the final stage of analysis: reviewing
against global objectives.
Reviewing practice against global PPM objectives
The PPM global objectives are stated in terms of
improved outcomes. In order to assess whether PPM
interventions have met these objectives it was important
to be clear whether a) the project publications presented
data relating to the outcomes and b) the study designs
enabled improvements in outcomes to be reasonably
attributed to the PPM interventions. We recognised that
the publications of the interventions did not set out to
answer these questions explicitly and that in some cases
measurement against these objectives was not consid-
ered a necessary part of the intervention design or
assessment. We therefore had to establish some criteria
to assess whether each publication presented data of
sufficient quality (for our purposes) to undertake such a
review.
We were keen to use a standardized tool for assessing
the quality of studies and so reviewed a number that are
employed in health and health systems research. The
nature of PPM as a complex intervention, however,
made this challenging. For example the Quality Assess-
ment of Diagnostic Accuracy Studies (QUADAS) [42]
tool was designed for diagnostics and clinical research
and simple interventions. A range of tools developed by
the Critical Appraisal Skills Programme (CASP) [43]
were also considered but required the evaluator to know
ap r i o r ithe detailed study design. In most of the 22
a  IEC = Information, Education and Communication 
Partner: 
Advocacy         ¥                           ¥
Cost coverage        ¥     ¥
Diagnosis     ¥       ¥   ¥                  ¥   ¥   ¥
Referal       ¥
Report                   ¥       ¥   ¥                  ¥   ¥   ¥  
Treatment     ¥       ¥   ¥                    ¥     ¥
Treatment support                 ¥
NTP:
Drugs   ¥       ¥   ¥                ¥   ¥   ¥
Lab equ i p m e n t                      ¥      
IEC
a Material                    ¥    
Supervision                ¥      ¥                  
Training                      ¥
PPM for TB Care and 
Control
Public-Private Partnerships Public-Public Partnerships
Other Public 
Sector
Private for 
Profit
Non Governmental 
Organisations (NGO)s
University 
hospitals
Ministry 
of 
Justice 
(Other 
Minist.)
Private 
Sector 
Workplace
(planned)
Private 
Hospitals 
Private
polyclinics
International 
NGOs
Health 
Services 
Implementers
Charity 
Hospitals
Community 
Mobilisation 
NGOs
Other 
PHC 
Progs.
HIV/AIDS
Health insurance 
1) Civil services
2) Social security
3) Universal 
coverage  
Other 
Ministries 
army, 
police, 
prisons 
Other Health 
Sector Partners
District
hospitals
General
hospitals
Local Govern. 
BMA
(Bangkok
Metropolitan
Admin.)
Figure 4 Nature and scope of PPM for TB Care and Control: example from Thailand.
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Page 6 of 19Table 1 Matrix illustrating extent of engagement of different partner groups from analysis of NTP manager interviews
PSHP
a OPS
b PFP
c NGO
d
Qual
clini
serv
e
Spec.
refer
serv
f
Other
ver.
Prog
g
Semi-
public
serv
h
Min.
provid
comm
living facil
i
Min. of
social
secur
j
Health
insurance
Other
ministries
Para-
statals
Qual
clini
serv
e
Qual
ancill
health
serv
k
Informal
providers
Work-place
programmes
Qual
clini
serv
e
Internationnal
NGOs
Informal
un-
qualified
providers
TOTAL
SCORE
SERVICES
Advocacy 3 0 3 0 2 1 1 2 3 1 01 3 2 1 4 2 7
Active
suspect
identification
00 0 0 0 0 0 0 0 0 00 0 0 0 1 1
Diagnosis 9 1 6 0 11 1 0 2 4 12 4 0 6 9 2 1 68
Referral 1 0 1 0 3 1 0 2 2 4 21 1 1 0 3 2 2
Treatment 9 2 6 0 11 1 0 2 4 12 20 5 9 1 2 6 6
Health
Education
00 0 0 0 0 0 0 0 0 00 0 1 0 0 1
Reporting 9 2 6 0 10 1 0 1 3 12 45 8 2 2 6 5
DOT
l 10 0 0 0 0 0 0 0 1 00 0 1 0 0 3
Treatment
support
00 0 0 0 1 0 1 0 0 01 2 0 1 5 1 1
Defaulter
tracing
00 0 0 0 0 0 0 0 1 00 0 1 0 0 2
Political
lobbying
00 2 0 0 0 0 3 0 0 00 2 0 0 0 7
Follow up of
work places
00 0 0 0 1 0 0 0 0 00 0 0 0 0 1
TOTAL
SCORE
32 5 24 0 37 7 1 13 16 43 12 3 24 32 7 18
INPUTS
ACSM/IEC
m 10 0 0 0 0 0 0 1 1 00 0 1 0 0 4
BCG
n 10 1 0 0 0 0 0 1 0 00 0 0 0 0 3
Diagnosis 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0
Drugs 4 0 3 0 9 1 0 2 4 9 1 0 3 7 2 2 47
Defaulter
tracing
00 0 0 0 0 0 0 0 0 00 0 0 0 0 0
Pay for
service
00 0 0 1 0 0 0 0 1 10 0 1 1 0 5
Diagnostic
supplies
20 1 0 5 0 0 0 2 6 00 2 7 0 0 2 5
Monitoring
supplies
10 0 0 1 0 0 0 0 2 00 0 1 0 1 6
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9Table 1 Matrix illustrating extent of engagement of different partner groups from analysis of NTP manager interviews (Continued)
Supervision 4 1 2 0 4 0 0 0 1 3 10 2 5 0 2 2 5
Capacity
building
30 1 0 6 1 0 0 2 5 11 3 5 0 2 3 0
Transport 0 0 0 0 1 0 0 0 0 0 00 0 0 0 0 1
TB-clinic
(building)
00 0 0 1 0 0 0 0 0 00 0 0 0 0 1
TOTAL
SCORE
16 1 8 0 28 2 0 2 11 27 4 1 10 27 3 7
NB: Highest ranking provider group, service type and input type are highlighted in bold.
a PSHP = Public Sector Health Partner
b OPS = Other Public Sector
c PFP = Private for Profit
d NGO = Non Governmental Organisation
e Qual. clin. serv. = Qualified clinical services
f Spec. refer serv. = Specialist referral services
g Other ver. prog = Other vertical programmes
h Semi public serv. = Semi-public services
i Min. provid. comm living facil = Ministries providing communal living facilities
j Min. of social secure = Ministry of social security
k Qual ancill health serv = Qualified ancillary health services
l DOT = Directly Observed Treatment
m ACSM/IEC = Advocacy, Communication and Social Mobilisation/Information, Education and Communication
n BCG = Bacille Calmette Guérin vaccine
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9Table 2 Matrix illustrating extent of engagement of different provider groups from analysis of literature.
PSHP
a OPS
b PFP
c NGO
d
Qual
clini
serv
e
Spec.
refer
serv
f
Other
ver.
Prog
g
Semi-
public
serv
h
Min.
provid
comm
living facil
i
Min. of
social
secur
j
Health
insurance
Other
ministries
Para-
statals
Qual
clini
serv
e
Qual
ancill
health
serv
k
Informal
providers
Work-place
programmes
Qual
clini
serv
e
Internationnal
NGOs
Informal
un-
qualified
providers
TOTAL
SCORE
SERVICES
Advocacy 0 0 0 0 0 1 0 1 0 0 00 0 3 1 2 8
Active
suspect
identification
10 0 0 0 0 0 0 0 2 01 0 2 0 2 8
Diagnosis 5 5 1 1 2 0 1 0 0 13 51 2 8 0 0 4 4
Referral 4 3 1 0 1 0 0 0 0 13 23 2 4 0 2 3 5
Treatment 5 5 1 1 2 0 1 0 0 16 1 4 2 8 0 0 46
Health
Education
01 0 0 1 1 1 0 0 0 00 0 2 0 2 8
Reporting 5 4 1 1 2 0 1 0 0 15 13 2 8 0 1 4 4
DOT
l 00 0 1 0 0 0 0 0 3 01 0 3 0 5 1 3
Treatment
support
00 0 0 0 0 0 0 0 1 01 0 0 0 5 7
Defaulter
tracing
10 0 0 0 0 1 0 0 1 01 0 7 0 4 1 5
Political
lobbying
00 0 0 0 1 0 0 0 0 00 0 0 0 0 1
Follow up of
work places
00 0 0 0 0 0 0 0 0 00 0 0 0 0 0
TOTAL
SCORE
21 18 4 4 8 3 5 1 0 64 9 15 8 45 1 23
INPUTS
ACSM/IEC
m 00 0 0 0 0 0 0 0 0 00 0 1 0 1 2
BCG
n 00 0 0 0 0 0 0 0 0 00 0 0 0 0 0
Diagnosis 0 0 0 0 0 0 0 0 0 2 00 0 2 0 2 6
Drugs 2 3 0 1 1 0 0 0 0 14 1 3 1 5 0 2 33
Defaulter
tracing
01 0 0 0 0 0 0 0 3 10 0 1 0 0 6
Pay for
service
00 0 0 0 0 0 0 0 0 10 1 0 0 0 2
Diagnostic
supplies
11 0 0 0 0 0 0 0 5 02 0 3 0 0 1 2
Monitoring
supplies
12 0 0 0 0 0 0 0 7 12 1 3 0 1 1 8
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9Table 2 Matrix illustrating extent of engagement of different provider groups from analysis of literature. (Continued)
Supervision 2 3 0 1 0 0 1 0 0 9 41 0 2 0 0 2 3
Capacity
building
24 0 1 1 1 1 0 0 13 41 0 3 0 2 3 3
Transport 0 0 0 1 0 0 0 0 0 1 00 0 0 0 0 2
TB-clinic
(building)
00 0 0 0 0 0 0 0 0 00 0 0 0 0 0
TOTAL
SCORE
81 4 0 4 2 1 2 0 0 54 12 9 3 20 0 8
NB: Highest ranking provider group, service type and input type are highlighted in bold.
a PSHP = Public Sector Health Partner
b OPS = Other Public Sector
c PFP = Private for Profit
d NGO = Non Governmental Organisation
e Qual. clin. serv. = Qualified clinical services
f Spec. refer serv. = Specialist referral services
g Other ver. prog = Other vertical programmes
h Semi public serv. = Semi-public services
i Min. provid. comm living facil = Ministries providing communal living facilities
j Min. of social secure = Ministry of social security
k Qual ancill health serv = Qualified ancillary health services
l DOT = Directly Observed Treatment
m ACSM/IEC = Advocacy, Communication and Social Mobilisation/Information, Education and Communication
n BCG = Bacille Calmette Guérin vaccine
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9projects reviewed, the interventions were usually clearly
described, but the study design used to measure the
effect was not explicitly stated, making the use of CASP
problematic. For example, in Kannur District, India, pri-
vate laboratories were engaged. The NTP gave free
training and quality assurance supervision. Numbers of
cases detected by the private laboratories and their
treatment outcomes were compared to numbers of
cases detected in the public sector. Total numbers of
TB cases detected in the 18 months prior to the inter-
vention were compared with numbers detected in the
18 months after the intervention was implemented. This
is, therefore, an observational study with a before-and-
after comparison, but this is not stated a priori [44].
Experts in systematic reviews for complex interven-
tions were also consulted to identify the most appropri-
ate review method.
The authors adapted common concepts from the tools
noted above to develop a data quality checklist compris-
ing the following dichotomous questions:
￿ Are any data presented?
￿ Are data compared to a study control arm?
￿ Are data compared to non-engaged private sector
providers in the locality?
￿ Are data compared to public sector providers in
the locality?
￿ Are data compared to country/regional data?
￿ Are there contemporaneous comparisons for any
of the above?
The authors developed review questions for each of
the global PPM objectives and used each question to
assess the literature against the data quality check list
above (see Table 3)
1.) Increase case detection
a.) Does the involvement of a given partner group
increase case detection?
2.) Improve treatment outcome
a.) Does the involvement of a given partner group
improve treatment outcome?
3.) Enhance access and equity
Table 3 Data availability for review against Global PPM objectives
Any data
presented
Data compared to: Data compared to
other involved
providers in locality
Projects for which any
quantitative data
presented*
Numbers of
programmes
for which:
Study
control
arm
Respectively Non-engaged
private or NGO
a providers
in locality
Public
sector in
locality
Country/
Regional
data
PFPs
b
Increase case
detection
16 4 2 14 11 10 A,B,F†,H,I,J,K,L,M,N,O,R†,S,
T,U,V
Improve
Treatment
Outcome
14 4 2 12 8 10 F†,B,H†,I,J,K,L,N†,P,R,S,T,
U†,V
Enhance Access
and Equity
83 4 516 F †,H,K,L,N,S,T,V
Reduce financial
burden on
patients
74 7 517 F †,H,K,L,S,T,V
NGOs
a
Increase case
detection
8 0 1 4 4 4 A,C,F,H,J,N,Q†,U
Improve
Treatment
Outcome
9 0 1 6 6 4 C,D,F,H,J,N,Q†,U
Enhance Access
and Equity
4 0 1 2 0 2 C,F†,H,N
Reduce financial
burden on
patients
20 1 202 F †,H
* Each letter identifies an individual project; it is the project i.d. for list of projects, please see figure 3
† Data are not disaggregated between different types of providers
a NGO = Non Governmental Organisation
b PFP = Private For Profit
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Page 11 of 19a.) Is the partner group geographically located in
areas where the population is predominantly poor?
b.) Does it provide services to demonstrable poor (e.
g. through assets measures), vulnerable or other
marginalised population groups?
c.) Has the engagement of the partner group altered
the proportion of women and men who access
services?
4.) Reduced financial burden on patients
a.) Does the involvement of the partner group
reduce the financial burden on patients?
b.) Do poor people (defined by local poverty mea-
sures) benefit from lower cost of treatment when the
partner group is engaged?
The most challenging of these was assessing equity in
interventions where this was not specifically an objective
of the individual projects. To do this as systematically as
possible, we followed the seven steps recommended for
assessment of equity in systematic reviews[45]. The
steps, along with a descriptor of how we achieved each
step, are outlined below:
(1) Developing a logic model: the construction of the
matrices
(2) Defining disadvantage and for whom interventions
are intended: the authors chose a definition of ‘the poor’
comprising three key indicators[40,46]:
a) Income (low income defined in the context of
local poverty lines)
b) Place of residence (rural and slum dwelling being
associated with poverty)
c) Agency within a household (low agency being
typically associated with female, gender and youth or
old age)
(3) Deciding on appropriate study design(s): an inclu-
sive approach toward individual study design was taken,
b u tw i t he x p l i c i ta s s e s s m e n t so fs t u d yq u a l i t ya g a i n s t
predefined criteria
(4) Identifying outcomes of interest: these were
selected based on the global PPM objectives
(5) Process evaluation and understanding context: It
was not possible to use process evaluation in this assess-
ment, but context has been clearly acknowledged
throughout
(6) Analysing and presenting data: the authors were
unable to present aggregate data or meta-analyses, but
have used the available data to make overall assessments
(7) Judging applicability of results: the results are
applicable in relation to global PPM objectives.
Findings
The findings are presented according to the different
objectives of the review outlined above.
Defining PPM for TB Care and Control - results from
STOP-TB PPM subgroup literature and e-mail clarifications
with the secretariat
As noted above, the original concept of PPM has
evolved. The Stop TB concept: “represent[s] a compre-
hensive approach to involve all relevant health-care pro-
viders in DOTS and ensure that they apply international
standards for TB care, while taking on DOTS tasks
according to their capacity. PPM DOTS targets a wide
range of public as well as private health-care providers
not yet sufficiently linked to NTPs. Depending on setting,
these may include medical colleges, general hospitals,
health services under specific insurance schemes, prison
health systems, army health services, NGO health facil-
ities, corporate health facilities, private specialists and
general practitioners, private pharmacies and the infor-
mal private health-care sector”.( D O T SE x p a n s i o n
Working Group Strategic Plan 2006-2015)[18].
The principles behind PPM for TB are: “that the
financial resources to establish and sustain the colla-
boration are provided or facilitated by the NTP, that
drugs are provided free of charge or heavily subsidized,
and that fees for tests and consultations are waived or
kept to a minimum”. (The Stop TB strategy WHO/
HTM/TB/2006.368)[16]. Clarification about the PPM
objectives was sought with the STOP-TB PPM subgroup
secretariat in November 2009. This confirmed the four
global objectives which were subsequently published in
the PPM toolkit [17].
Defining PPM for TB Care and Control - results from NTP
manager interviews
At country level, the understanding and implementation
of PPM activities varied considerably. For example in
Pakistan only qualified private providers were involved
in PPM activities; in Thailand the NTP worked together
with a broad spectrum of care providers, including pub-
lic hospitals, other public health care programs, the
armed services, other workplaces and health insurers;
and in Brazil TB care was only provided by the public
sector but the private sector was used to ensure contin-
ued political support for the public TB services, to sup-
port social movement activities and to promote TB
workplace activities.
Understanding of PPM by some NTP managers had
also changed over time, as PPM itself evolved. Some
NTP managers stated that their initial understanding of
PPM was that it related to the private for-profit sector,
although they had expanded to work with a number of
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Page 12 of 19different providers. One respondent stated “five years
ago I was surprised when I came here [WHO Geneva]
and was told that PPM also included other providers
like public-public. I was of the opinion that PPM meant
working with private for profit GPs only”.
In many countries activities that could be considered
PPM, in that they engage non-NTP actors, were not
seen as such. For example in Cambodia, Myanmar and
Mozambique the NTPs were engaging in partnerships
with various types of community organizations and
community providers, but did not recognize this as
PPM and so did not report it as such.
Mapping country-level partners and interventions
Most PPM publications referred to projects in Asia (Fig-
ure 2). Findings from the NTP manager interviews
(Table 1) and from the publications (Table 2) were con-
sistent in reporting that private for profit (PFP)-qualified
clinical services (QCS) were the most frequent partner
for their PPM programmes. The interviews (table 1)
ranked the other public service (OPS) ministries provid-
ing communal living facilities (such as prisons and army
barracks) second, while the NGO-QCS and the public
sector health partners (PSHP)-QCS equally were the
third most common partners. The publications (Table
2) ranked the NGO-QCS as the second and the NGO-
unqualified providers as the third most common part-
ner. Overall the NGO-QCS was the second most com-
mon type of partner.
It was clear that concepts of partnership varied. In
some cases partners provided a limited range of services,
while in others, they provided the majority. In Bangla-
desh, according to the NTP manager, BRAC provided
TB support services to the general population in part-
nership with the NTP and additionally supervised 28
smaller NGO’s and through them supported TB services
in the army, police and prison system with resources
and technical assistance.
The NTP managers (table 1) cited diagnosis, drug
treatment and reporting as being equally common ser-
vices while Table 2 shows that according to the litera-
ture, drug treatment was the service most frequently
provided, followed jointly by diagnosis and reporting.
Table 1 show that partners were supported by NTP
inputs in the form of providing drugs and capacity
building. The literature (table 2), also showed that drugs
and capacity building were the most common NTP
inputs.
Reviewing practice against global PPM objectives
This was challenging due to the lack of systematic
reporting of projects against the PPM objectives. Table
3 shows the characteristics of the study designs and the
data presented in the project documents relating to the
identified PFP- and NGO-QCS interventions. The num-
ber of projects reporting on case detection and treat-
ment was higher than projects reporting on access,
equity and cost reduction. Furthermore the quality of
reported data, measured against our checklist, was also
better for case detection and treatment outcome.
￿ Case detection
The definition of case detection was noted in the intro-
duction. However there are a number of activities that
contribute to case detection, not all of which require
biomedical training. For example “active suspect identifi-
cation” and “referral” are linked to the clinical aspect of
case detection, but may be performed by individuals
with a non-medical background [47]. Case detection was
incorporated into PPM projects, but reported in sub-
components such as advocacy, diagnosis or referral.
Four of the projects working with PFP-QCS had a
control arm, and presented evidence that showed
increased case detection. In New Delhi, India there was
a near doubling of cases in the PPM project area com-
pared to the control area[48,49]. In Myanmar the
increase in both PPM project areas was higher than the
contemporaneous increase in the control area. For
example new smear positives rose from 46 to 85 per
100,000 between 2001 and 2004, compared to 23 to 36
per 100,000 over the same period in the control area
[30,50,51]. In the study from Hyderabad, it is interesting
to note that similar proportions of patients were
referred from PFP- and NGO-QCS (42% and 46%
respectively) while fewer were referred from PFP- Infor-
mal providers (33%). One study noted that case detec-
tion benefits can be achieved through the impact that
engaging private providers can have on awareness of
services: Newell et al.[52] found that after some time,
many patients by-passed PFP-QCS and went directly to
the DOTS centres linked to them, which were primarily
NGO-run.
None of the NGO studies had a control arm, but
there did appear to be an increase in case detection in
before and after comparisons. Many of the NGOs were
partners alongside PFP-QCS; it was not often clear what
each of these contributed. In Indonesia[53] for example,
the NGO facility diagnosed all the cases referred from
multiple sources. Other studies noted increased case
detection in the project areas, however it is not possible
to directly attribute this to the intervention due to non-
disaggregated data between provider types, and a lack of
either a comparator area or a comparison with underly-
ing trends in case detection.
It appears from some studies that increased case
detection from PFP-QCS partners relied on the payment
of incentives or on a mediating NGO and that when
these were removed case detection declined
[27-30,49,54-56].
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Treatment success rates in most of the countries report-
ing PPM activities with PFP-QCS were generally high in
both the public sector and with PPM partners, particu-
larly NGOs (often over 85% and sometimes over 90%),
providing little scope for substantial improvement. It is
only in the projects with a control arm that any change
can be attributed with reasonable certainty to the PPM
interventions. In some countries treatment outcomes
among private providers were poor and demonstrated
marked improvement after inclusion in a PPM pro-
gramme. For example, the New Delhi project[34]
reported that the number of successfully treated cases
(all categories) was higher in the PPM project (n = 204)
than the non-DOTS treatment in the private sector (n =
121) by a factor of 69%. The treatment success rate
(new smear positive) in the project was 81%, not statisti-
cally different from 86% in the Government Chest Clinic
nor 82% in the broader public sector for New Delhi
[34,48]. In Vietnam, treatment success rates among pri-
vate providers improved from 49% to 62% through
engagement in the PPM intervention, but remained sub-
stantially lower than the 87% achieved through the NTP
[29,57]. In Nigeria[58] treatment success rates with the
NGO partners (83.7%) and the public sector (78.6%)
where not statistically significant different, but the
default rates were lower with the NGO partner (5,8%)
than in the public sector (13%).
The Myanmar Sun Quality Health (SQH) franchise
[51] study provided an equity analysis on treatment out-
comes and found that people with low socio-economic
status had significantly lower treatment success rates
than people from higher socio-economic groups within
the project. Treatment success rates among higher
socio-economic groups were 94% compared with 84% in
lower socio-economic groups (P = 0.021)[51].
￿ Enhance access and equity
Some PPM interventions showed greater potential than
others for increasing equity in access to TB services by
being located predominantly in poor areas or serving
poor population groups. Projects in Hyderabad,
[31,34,59] Mumbai,[60,61] Myanmar,[50,51] South
Africa[62] and Nepal[63] provided examples of these,
while in the Philippines[64] the NGO was located in
metro Manila which is a relatively wealthy location and
in Kenya[65] the partners were located outside the
slums.
Some studies provide more detailed equity analysis.
For example the Myanmar SQH franchise[51] study
showed that 48% of patients belonged to the lowest
socio-economic quintile. The Bangalore[32,33] study
presented the socio-economic profile of patients, show-
ing that 50% had a low standard of living. It also showed
that almost 50% of each of the lowest, middle and
highest income groups where referred for TB diagnosis
by a private practitioner. Total expenditure during care
seeking for the lowest income group was US$120 vs. US
$170 for high and medium income groups, however this
constituted respectively 53% and 41% of annual house-
hold income per capita. Unfortunately data are not dis-
aggregated between qualified and unqualified private
providers. Some of the NGO-CQS projects were work-
ing with particularly marginalised groups in order to
increase their access to TB services. In Egypt[54] for
example, the NGO partner worked with African refu-
gees who have poor access to public TB services. During
the duration of the study in Nepal,[52,63,66] patients
bypassed the PFP-QCS and went straight to the involved
NGO hospital, similarly in Hyderabad[31,34,59] 51% of
patients with suspected TB presented directly to the
involved NGO hospital.
Many of the projects did not describe their location or
provide information on the socioeconomic status of
their patients. Some provided details of urban or rural
location; in many countries rural areas are poorer, and
it may be surmised that the rural projects in Thatta,
Pakistan[56] and Pune[29,30,49,55] may have served
mostly poor people. Others provided information on
how efforts were made to increase access for the poor.
One project in Nepal[52,63,66] for example aimed to
ensure that patients did not have to travel more than 15
minutes to reach the nearest DOTS centre.
Some projects seemed less successful in reaching
poorer patients, although the patients accessing services
were by no means wealthy. In New Delhi[34,48], for
example, the patients were predominately literate, lived
in semi-urban areas, were employed in private establish-
ments and belonged to the middle-income group, with
an average monthly income of reported to be US$40.
Some studies reported gender differences in access to
care and the change the projects made to this. For
example in project areas in Hyderabad[31,34,59] the
proportion of new smear positive women was reported
to be higher than in the rest of Hyderabad (46% vs.
37%), unfortunately it was not possible to differentiate
among the partners types to determine which made
most contribution to the change.
￿ Reduce financial burden for patients
Among the few studies that reported against this objec-
tive, it appears that the costs to patients consulting PFP-
QCS within a PPM programme were substantially less
than those for patients visiting similar practitioners not
engaged in the programme, the main reason being sub-
stantially lower expenditure on drugs [34]. For example,
the New Delhi[34] study reported costs per patient visit-
ing PFP-QCS involved in the PPM project as US$50-60,
which, while still high, was approximately one third of
the cost faced by patients consulting with private
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mar studies[30,50,51] it was reported that costs were
expected to be lower (one provided high levels of subsi-
dies to partners), but actual costs were not provided.
A comparative study was undertaken in Hyderabad,
[27,28,30,31,34,59,67] where it was reported that
patients visiting PFP-QCS were diagnosed faster than in
the public sector (8 vs. 10 weeks), paid less prior to
diagnosis (US$5 compared with US$20), paid less during
treatment (US$1 compared with US$11) and lost less
income due to illness (1.4 against 2.8 months of lost
wages). The total patient cost when attending a private
partner of the PPM programme was US$50-60, while
for non-DOTS treatment in the private sector, mean
costs were US$111.
It appeared that the NGO projects tended to charge
lower fees to patients. In the Egyptian[54] project, for
example, drugs were provided for free and any patient
needing inpatient care received it free of charge. Where
there were charges sometimes part was refunded. In
Timika[53] for example, patients were asked to deposit
approximately US$20 which was paid back when the
treatment was completed; there were exemptions for
local patients of a specific ethnicity and for those who
were very financially constrained.
Some studies had less positive findings. In some coun-
tries patients still pay for all or some aspects of diagno-
sis, even when private providers have been trained in
DOTS (e.g. Kenya, [28-30,65] Chennai,[27,28,68] Kerala
[30,31,35,44,69]). In some places, treatment is still
charged for under PPM and is costly for patients and
particularly for the poor. In Vietnam[57,70,71] it was
stated that patients visiting PFP-QCS paid for treatment,
but defaulted because they could not afford it: the
monthly drug cost varied between US$12 and US$33
while 41% of patients earned less than US$40 per
month. In many countries PFP-QCS continued to
charge consultation fees.
Most studies however did not report patient costs,
even fewer compared them to average patient incomes
or socioeconomic status, and few of those that did
report costs had a comparison arm. It is therefore not
possible to say, for many projects, whether total costs
for patients visiting the private sector have reduced as a
result of PPM and whether these are lower than for
patients visiting the public sector. Without an analysis
of socioeconomic status it is not possible to say what
proportion of average income is spent by patients acces-
sing services.
Discussion
’Engaging all care providers’ is a strategy that can
increase access to TB care and has done so in a number
of countries. The strategy has the potential to do this
for the poor and again, has done so in some places. It
became clear through the interviews and the literature
however that the breadth of PPM is not being explored
in practice and that most projects currently are focussed
on formal private for profit practitioners, with NGO
qualified providers a secondary focus; with some evi-
dence that NGO providers can offer greater gains in
equity and patient cost reduction. Involvement of for-
profit qualified providers are also most frequently men-
tioned in previous evaluations and cross project studies
[27-31], however a systematic analysis of the implica-
tions of this has not been published.
The predominance of partnerships with qualified
clinical service providers and particularly with private
for profit practitioners is understandable given that the
original motivations for PPM were to improve the
quality of services received by patients who went to
private providers. It is recognised, however that there
is substantial country level interaction between public
sector bodies under PPM, however it is not possible to
assess the impact of these due to a lack of publica-
tions, which may be indicative of a lack of evaluations
of output of such PPM setups. It is encouraging to see
that efforts have been made to engage NGOs and it
appears that this has contributed to access by poorer
populations. There is however an array of other provi-
ders, particularly for-profit informal providers, who are
accessed by the poor and who are not explicitly incor-
porated into PPM programmes. There does not appear
to have been any assessment of the contribution they
make to case detection, treatment success and
increased equity in access to services. In some cases it
seems that this is because they are considered by pro-
gramme managers to be part of a community DOTS
rather than a PPM approach. It was not possible to
review the community DOTS literature as part of this
review, thus it is not clear whether the role and effec-
tiveness of for-profit informal providers is documented
elsewhere.
An interesting finding from the interviews was that
while partnerships with other parts of the public sector
were clearly important and frequently conducted, they
were not mentioned in the publications. There may be a
number of reasons for this. Some evaluations excluded
this type of PPM intervention, either explicitly [31] or
through defining PPM as the link between the national
TB programme and private for-profit providers and
NGOs [27-30]. Another reason is that NTP managers
have formal links with other parts of the public sector
through the Minister of Health who will hold discus-
sions with the heads of other ministries at cabinet level.
It may be that the limited need for technical assistance
also means that there are fewer publications about pub-
lic-public partnerships.
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types is unimportant since one of the principles of PPM
is that the objectives are defined locally. However it
d o e sa p p e a rf r o mt h ee v i d e n c et h a tc h o i c eo fp a r t n e r
affects the outcomes of PPM interventions in terms of
case detection, treatment success, access by different
socio-economic groups and poverty alleviation. In the
projects that have been able to demonstrate increased
access for poor and other marginalised people it is clear
that the designers and implementers strategically chose
partners to which poor people have geographical, social
and (sometimes) financial access. In many sites this was
done through reducing the economic cost to patients (in
terms of money and also time spent care seeking); in
Egypt a new service was created for those who could
not access the public health services.
Most projects report some level of geographical infor-
m a t i o n( e . g .r u r a l ,u r b a n ,p e r i - u r b a n ) ,s o m e t i m e sa sa
proxy for poverty. Few provide data on distances tra-
velled by patients to access services by different types of
providers. In future studies Geographic Information Sys-
tems techniques may be used to support spatial map-
ping of providers, which could help with partner
selection and provide information about the equity of
interventions through identifying whether quality ser-
vices are being taken closer to patients [72-74].
With the exception of using geographical markers, it
was difficult to draw conclusions about whether the
selected partners increased equity in access to services,
due to the limited availability of socioeconomic data. In
another assessment, Lönnroth et al. found that only one
out of four studied projects could be said to increase
access and equity [29].
Limitations
The authors recognise a number of limitations to the
review methodology as well as limitations to the avail-
ability and analysis of evidence.
The first limitation is the lack of standardised meth-
ods for assessing complex interventions. As noted
above, several assessment frameworks were considered,
b u tn o n ew e r es u i t e dt op r o v i d i n gab a s i sf o ra s s e s s i n g
complex interventions using mixed methods research.
Furthermore, the method we chose for identifying the
predominant types of interventions is open to criticism.
We used a scoring system to assess the frequency with
which partners were engaged by NTPs as reported by
NTP managers and in the published literature. While
such a method provides an approximation of the types
of PPM models in practice it does not capture the
importance of the different elements of the project, for
example whether it is weighted toward case detection or
to improving quality of treatment. Further we were only
able to analyse the detail of the projects among the
predominant types of partner. It may be that some pro-
jects using less frequently reported partners had better
outcomes in terms of case detection or equity.
As noted in the methods, assessing equity was challen-
ging. Most project evaluations did not consider differ-
ences in socio-economic status of the patients visiting
different types of provider. When programmes involved
more than one type of for-profit provider the data were
not spilt between these providers (for example qualified
and unqualified practitioners), nor was this seen as a
concern within those evaluations [27-31].
The review was also limited with regard to the way it
was able to assess the contributions of multiple partners
to a single project; for example, we have not been able
to explore the contributions of different agents, such as
medical associations. We focussed instead on the part-
ners with whom patients have direct contact. This lim-
itation arose largely from the lack of detail in
publications, however we do not see this as a significant
limitation, since it is the contact partner (e.g. the pri-
vate-for profit practitioner) that most influences the
patient’s experience of care.
There were also limitations relating to data avail-
ability. Some (unpublished) reports were not available
t ot h ea u t h o r s ;w ew e r ea l s oo n l ya b l et oi n t e r v i e w
12/22 NTP managers from high burden countries.
Both these concerns mean that some forms of part-
nership may not have been included in the analysis.
However from the data available and the consistency
of engagement particularly regarding partner type, we
do not believe that the conclusions would have chan-
ged substantially.
Conclusion
PPM has had success in improving case detection and
treatment outcomes among patients seeking care with
private partners. Evidence for reduced costs for the
patients is inconclusive however, and there is still scope
for increasing equity in access to care, by systematically
engaging providers who are the primary agents for poor
people seeking health care.
Guidelines outlining which types of providers best
contribute to achieving the four global objectives,
along with the resources (financial, human and other)
required by NTPs for such engagement would assist
with decisions about which type of providers to
engage.
I tw o u l db eu s e f u li fe v a l u a t o r so fp r o g r a m m e ss y s -
tematically consider all the four global PPM objectives
in their analyses: if equity is being measured then the
chances of it being delivered improve also. Such analysis
would help policy makers at national and international
level identify gaps in service provision and think crea-
tively about how to address them.
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Additional file 1: Overview of providers and aggregated provider
groups. The table shows all the named providers in the interviews with
the National Tuberculosis Programme managers, in addition to showing
which of the individual providers make up each of the aggregated
provider groups used in table 1 and 2.
Additional file 2: Overview of service provided by providers. The
table shows all the types of service provided by the providers in addition
to showing which of the individual service make up each of the
aggregated provider service used in table 1 and 2.
Additional file 3: Overview of National Tuberculosis Programme
inputs received by provider. The table shows all the types of National
Tuberculosis Program inputs received by providers in addition to
showing which of the individual inputs make up each of the aggregated
National Tuberculosis Programme inputs used in table 1 and 2.
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